Omnicell OMCL Return on equity

Return on equity at other companies

Baxter InternationalBAX

-16.7%-76.7pp

Becton, Dickinson and CompanyBDX

3.8%-2.4pp

BrightSpring Health Services, Inc.BTSG

16.9%—

ICU MedicalICUI

-0.4%-0.2pp

Nutex Health Inc.NUTX

57.2%+19.3pp

InfuSystem HoldingsINFU

13.9%+8.0pp

FAQ

What is Omnicell's return on equity?

Omnicell (OMCL) reported return on equity of 1.6% in Q3 2025.

How has Omnicell's return on equity changed year-over-year?

Omnicell's return on equity increased by 211.1% year-over-year, from -1.5% to 1.6%.

What is the long-term trend for Omnicell's return on equity?

Over 3 years (2020 to 2024), Omnicell's return on equity has grown at a -33.8% compound annual growth rate (CAGR), from 3.6% to 1%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.